Cargando…

Relationship between WBRT total dose, intracranial tumor control, and overall survival in NSCLC patients with brain metastases - a single-center retrospective analysis

BACKGROUND: The relationship between whole brain radiotherapy (WBRT) dose with intracranial tumor control and overall survival (OS) in patients with non-small cell lung cancer (NSCLC) brain metastases (BM) is largely unknown. METHODS: We retrospectively analyzed 595 NSCLC BM patients treated consecu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Zhensheng, Shen, Dongxing, Zhang, Jian, Zhang, Jun, Yang, Fang, Kong, Deyou, Kong, Jie, Zhang, Andu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854885/ https://www.ncbi.nlm.nih.gov/pubmed/31727054 http://dx.doi.org/10.1186/s12885-019-6307-8

Ejemplares similares

Efficacy and safety of WBRT+EGFR‐TKI versus WBRT only in the treatment of NSCLC patients with brain metastasis: An updated meta‐analysis
por: Zhou, Kai, et al.
Publicado: (2021)

Continuous Low-Dose Apatinib Combined With WBRT Significantly Reduces Peritumoral Edema and Enhances the Efficacy of Symptomatic Multiple Brain Metastases in NSCLC
por: Ren, Yue, et al.
Publicado: (2021)

Survival and intracranial control outcomes of whole-brain radiotherapy (WBRT) alone versus WBRT plus a radiotherapy boost in non-small-cell lung cancer with brain metastases: a single-institution retrospective analysis
por: Lu, Fei, et al.
Publicado: (2019)

Clinical outcomes of WBRT plus EGFR-TKIs versus WBRT or TKIs alone for the treatment of cerebral metastatic NSCLC patients: a meta-analysis
por: Zheng, Hong, et al.
Publicado: (2017)

RADI-01. PROGNOSTIC FACTORS OF SHORT SURVIVAL FOR BRAIN METASTASES TREATED WITH SRS WITHOUT WBRT.
por: Harat, Maciej, et al.
Publicado: (2019)

Osimertinib Improves overall survival of EGFR-mutant NSCLC patients with leptomeningeal metastases
por: Ye, Qiuyue, et al.
Publicado: (2023)

Whole brain radiotherapy (WBRT) for leptomeningeal metastasis from NSCLC in the era of targeted therapy: a retrospective study
por: Zhen, Junjie, et al.
Publicado: (2020)

Whole brain radiotherapy (WBRT) after local treatment of brain metastases in melanoma patients: Statistical Analysis Plan
por: Lo, Serigne N., et al.
Publicado: (2019)

WBRT for brain metastases from non-small cell lung cancer: for whom and when?—Contemporary point of view
por: Sas-Korczynska, Beata, et al.
Publicado: (2021)

MLTI-02. A PHASE I TRIAL OF SORAFENIB WITH WHOLE BRAIN RADIOTHERAPY (WBRT) IN BREAST CANCER PATIENTS WITH BRAIN METASTASES AND A CORRELATIVE FLT-PET BRAIN IMAGING STUDY IN PATIENTS RECEIVING WBRT +/- SORAFENIB
por: Morikawa, Aki, et al.
Publicado: (2019)

Reduced-dose WBRT combined with SRS for 1–4 brain metastases aiming at minimizing neurocognitive function deterioration without compromising brain tumor control
por: Nakano, Toshimichi, et al.
Publicado: (2022)

Reduced-dose WBRT as consolidation treatment for patients with primary CNS lymphoma: an LOC network study
por: Lesueur, Paul, et al.
Publicado: (2022)

Association of radiation dose intensity with overall survival in patients with distant metastases
por: Kao, Johnny, et al.
Publicado: (2021)

Survival time following resection of intracranial metastases from NSCLC-development and validation of a novel nomogram
por: Ji, Xiaoyu, et al.
Publicado: (2017)

RADVAN: a randomised phase 2 trial of WBRT plus vandetanib for melanoma brain metastases – results and lessons learnt
por: Gupta, Avinash, et al.
Publicado: (2016)

WBRT vs. APBI: an interim report of patient satisfaction and outcomes
por: Bitter, Samantha M., et al.
Publicado: (2016)

Increasing Heart Dose Reduces Overall Survival in Patients Undergoing Postoperative Radiation Therapy for NSCLC
por: Shepherd, Annemarie F., et al.
Publicado: (2021)

The overall survival benefit in Chinese ALK(+) NSCLC patients received targeted therapies
por: Tian, Guangming, et al.
Publicado: (2022)

Serum total periostin is an independent marker of overall survival in bone metastases of lung adenocarcinoma
por: Massy, E, et al.
Publicado: (2021)

Whole brain radiation therapy does not improve the overall survival of EGFR-mutant NSCLC patients with leptomeningeal metastasis
por: Yan, Weiwei, et al.
Publicado: (2019)

Static beam tomotherapy as an optimisation method in whole‐breast radiation therapy (WBRT)
por: Squires, Matthew, et al.
Publicado: (2017)

RADI-16. Efficacy of WBRT among the Sub-types of Metastatic Breast Cancer
por: Mathew, Shija, et al.
Publicado: (2021)

Higher Radiation Dose to the Immune Cells Correlates with Worse Tumor Control and Overall Survival in Patients with Stage III NSCLC: A Secondary Analysis of RTOG0617
por: Jin, Jian-Yue, et al.
Publicado: (2021)

Intracranial efficacy of alectinib in ALK-positive NSCLC patients with CNS metastases—a multicenter retrospective study
por: Zou, Zihua, et al.
Publicado: (2022)

Intracranial and Extracranial Progression and Their Correlation With Overall Survival After Stereotactic Radiosurgery in a Multi-institutional Cohort With Brain Metastases
por: Carpenter, David J., et al.
Publicado: (2023)

Upfront brain radiotherapy improves intracranial progression-free survival but not overall survival in lung adenocarcinoma patients with brain metastases: a retrospective, single-institutional analysis from China
por: Jiang, Aijun, et al.
Publicado: (2022)

Circulating DNA: Diagnostic Tool and Predictive Marker for Overall Survival of NSCLC Patients
por: Catarino, Raquel, et al.
Publicado: (2012)

Locally dose-escalated radiotherapy may improve intracranial local control and overall survival among patients with glioblastoma
por: Zschaeck, Sebastian, et al.
Publicado: (2018)

Ferroptosis-Related Genes Are Potential Therapeutic Targets and the Model of These Genes Influences Overall Survival of NSCLC Patients
por: Zhang, Na, et al.
Publicado: (2022)

Management of Intracranial Metastases in EGFR-Mutated NSCLC: A Review of Literature following an Unusual Case Report
por: Albarrán, Víctor, et al.
Publicado: (2021)

Overall survival nomogram for patients with spinal bone metastases (SBM)
por: Osong, Biche, et al.
Publicado: (2021)

Association of the Cumulative Dose of Radioactive Iodine Therapy With Overall Survival in Patients With Differentiated Thyroid Cancer and Pulmonary Metastases
por: Yang, Jing, et al.
Publicado: (2019)

Best Supportive Care Versus Whole-Brain Irradiation, Chemotherapy Alone, or WBRT Plus Chemotherapy in Patients With Brain Metastases From Small-Cell Lung Cancer: A Case-Controlled Analysis
por: Li, Hongwei, et al.
Publicado: (2021)

The Efficacy of Upfront Intracranial Radiation with TKI Compared to TKI Alone in the NSCLC Patients Harboring EGFR Mutation and Brain Metastases
por: Wang, Chunyu, et al.
Publicado: (2019)

Nomograms integrating CT radiomic and deep learning signatures to predict overall survival and progression-free survival in NSCLC patients treated with chemotherapy
por: Chang, Runsheng, et al.
Publicado: (2023)

Setup uncertainties and appropriate setup margins in the head-tilted supine position of whole-brain radiotherapy (WBRT)
por: Park, Jae Won, et al.
Publicado: (2022)

Descriptive analysis of and overall survival after surgical treatment of lung metastases
por: Poletti, Giana Balestro, et al.
Publicado: (2013)

Palliation of Brain Metastases: Analysis of Prognostic Factors Affecting Overall Survival
por: Rastogi, Kartick, et al.
Publicado: (2018)

Does resection improve overall survival for intrahepatic cholangiocarcinoma with nodal metastases?
por: Sweigert, Patrick J., et al.
Publicado: (2020)

Lung and bone metastases patterns in osteosarcoma: Chemotherapy improves overall survival
por: Tang, Liyuan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p3b363pu4mg9jk1b5q8abbamma